Athelas Stock

athelas.comHealthcare / Digital HealthFounded: 2016Funding to Date: $152.51MM

Athelas is a healthcare business whose core product, Athelas Home, is an at-home blood diagnostics device requiring a finger prick to produce health insights. Other Athelas products, including their Scribe for healthcare providers and PillTrack, are on the market. Athelas was founded in 2014 by Tanay Tandon and Deepika Bodapati and is headquartered in Mountain View, CA.

Register for Details

For more details on financing and valuation for Athelas, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Athelas.

Register Today

Team

Management Team

Tanay Tandon
Co-Founder & Chief Executive Officer
Dhruv Parthasarathy
Chief Technology Officer

Board Members

Alfred Lin
Sequoia Capital
Arjun Sethi
Tribe Capital
Hemant Taneja
General Catalyst

Other companies like Athelas in the Digital Health sector

Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$3.66B
Sector
Last Round Est. Valuation
$2B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.13B
Sector
Last Round Est. Valuation
$2.62B
Sector
Last Round Est. Valuation
$6.2B

News Highlights

Remote patient monitoring is raking in venture funding
As COVID-19 dials up demand on health systems large and small, startups offering to unload some of the burden with digital devices are raking in the cash.
Health Startup Athelas Hits $1.5 Billion Valuation After Pandemic Boom
Athelas Inc., a startup that builds remote patient monitoring technology, raised $132 million in new funding, bringing its valuation to $1.5 billion.
Updated on: Sep 24, 2023